Middle East & Africa Genome Editing Market Size & Outlook
Middle East & Africa genome editing market, 2018-2030 (US$M)
Related Markets
MEA genome editing market highlights
- The MEA genome editing market generated a revenue of USD 341.7 million in 2023.
- The market is expected to grow at a CAGR of 12.9% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 341.7 million |
| Market revenue in 2030 | USD 797.0 million |
| Growth rate | 12.9% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.3% of the global genome editing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,743.8 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 45.8% in 2023. Horizon Databook has segmented the Middle East & Africa genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa genome editing market is majorly driven by continuous efforts undertaken by researchers of various academic institutions and laboratories, to expand awareness and knowledge about genome editing technologies.
For instance, in November 2019, the South African Medical Research Council (SAMRC) and the faculty of health science of the University of Witwatersrand conducted the first South African conference on gene editing to discuss the ethical & legal issues of genome editing and share appropriate & relevant recommendations.
Growing interest in gene editing technologies has been stimulated by the expanding gene therapy market, contributing to its growth. In South Africa, research into somatic cell gene therapy, which includes gene editing technologies, is primarily directed towards addressing prevalent disorders such as hepatitis B, HIV, cancer, and tuberculosis.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA genome editing market size, by country, 2018-2030 (US$M)
Middle East & Africa Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
